Добавил:
kiopkiopkiop18@yandex.ru t.me/Prokururor I Вовсе не секретарь, но почту проверяю Опубликованный материал нарушает ваши авторские права? Сообщите нам.
Вуз: Предмет: Файл:

Ординатура / Хирургия / Библиотека им академика М.И. Перельмана / Книга_5355_Библиотеки_им_академика_М_И_Перельмана

.pdf
Скачиваний:
0
Добавлен:
31.08.2026
Размер:
27 Мб
Скачать
https://t.me/med1917
104
Handbook of 3D Printing in Pharmaceutics
a concern. Fusion- based AM technologies use heat to melt the powder layers, which causes residual tension in the nished product. Because the BJ method uses relatively little heat, heat- induced stress and distortion are quite rare. Various densities with controlled porosity are obtained on sintering temperature and time. It involves several steps and requires post- processing. Due to the relatively low relative density of the printed pieces, densication in this state typically causes severe geometric distortion. Compared to powder bed fusion, there is a higher surface roughness and lesser reso­lution. For the bulk materials, post- processing strategy development is still necessary (Danae Karali et al., 2012).
6.2 PHARMACEUTICAL APPLICATIONS OF BINDING JETTING
(PERSONALIZED MEDICINE AND DOSAGE FORMS)
6.2.1 custOmizeD Drug DOsing anD FOrmulatiOns
Two methods exist for incorporating pure medications into the mixture (Goole et al.,
2016). According to one method, the solvent and binder are the only ingredients in the cartridge after the API and excipients are well combined into a printed powder. As an alternative, API can be sprayed onto the powder bed in the form of a sus­pension or solution. According to Goole et al. (2016), the nal dispersible tablets created using 3D printing had a uniform drug content, improved mechanical qualities, and a highly porous structure that accelerated the rate of disintegration as shown in Figure 6.1. A children’s formulation with an eye- catching appearance and instant release properties was created using color inkjet three- dimensional printing (CJ- 3DP) and a binder. The tablet strength and model volume showed a consistently linear rela­tionship (>0.999).
6.2.2 Patient- sPeciFic imPlants anD meDical DeVices
Drug implants created through 3D printing may have unique morphologies and intricate release schedules for every patient. Through the use of two potential water- soluble adhesives, technology was able to replace bone with hydroxyl apatite (HA) in the chemical composition phase and real bone in the inorganic phase. An implant made of bone tissue was coated with HA powder in order to improve the bond between the powdered HA and the HA in the implant. Micro- architecture, manufacturing precision and appropriate mechanical properties of the phosphoric acid implants was superior to those of the polyvinyl alcohol implants. The study also showed how varied HA and tricalcium phosphate (TCP) composition ratios affected
FIGURE 6.1 Structure diagram for the 3D- printed formulation. (Hong X et al., 2021)
https://t.me/med1917
Binder Jetting
TABLE 6.1
105
Examples of Rapid- Release Formulations used in BJ3DP
Dosage form API Powder Binder References
Dissolving
tablets
Dispersible
tablets
Fast dissolving
tablets
Oral
disintegrating tablets
Dispersible
tablets
Oral
disintegrating tablets
Levetiracetam Microcrystalline
cellulose, mannitol, colloidal silicon dioxide (CSD), PVP
Ketoprofen Spray dried lactose
monohydrate, spray- dried lactose, microcrystalline cellulose, mannitol, PVP grade K25, silica.
Indomethacin Lactose monohydrate
Kollidon VA64 (KL)
Warfarin
sodium
D- sucrose,
pregelatinizedstarch, Povidone K30, Microcrystalline cellulose, silicon dioxide
Clozapine Mannitol, lactose,
microcrystalline cellulose, straw berry avor, colloidal silicon dioxide
Andrograp-
holide
Sucrose, mannitol, PVP
K30, microcrystalline cellulose, aspartame
40% (v/ v)
isopropanol aqueous solution containing
0.05% (w/ w) PVP and 4% (w/ w) glycerin
Ethanol solution
with 10% polyethylene glycol 1500
5% (W/ V) KL in
water
38% (v/ v) ethanol
solution
50% (v/ v) ethanol
solution containing 0, .3 (w/ w) PVP and 4% (w/ w) glycerin
30% (v/ v) ethanol
solution
Wang Z et
al., 2021
Kreft K et
al., 2024
Chang S- Y
et al., 2020
Tian P et
al., 2018
Chen R et
al., 2021
Huang SY
et al., 2020
mechanical properties (Pandey et al., 2020). Table 6.1 provides examples of rapid- release formulations used in BJ3DP.
6.3 NOVEL DRUG DELIVERY SYSTEMS
6.3.1 sustaineD release FOrmulatiOns
To the rst controlled- release 3D- printed tablet was created using alizarin yellow and methylene blue as model drugs. Second, acetaminophen served as the model drug for pie- shaped controlled- release. Third, lactose, HPMC, and PVP were combined to create an intermediate layer in an API gradient oral controlled- release drug- delivery
https://t.me/med1917
106
Handbook of 3D Printing in Pharmaceutics
system; BJ3DP and dissolved diclofenac sodium in the binder were used to create the top and bottom layers (Goole et al., 2016).
6.3.2 multi- Drug cOmBinatiOn PrODucts
PN- containing solutions and blank printing solutions were the two categories into which the printing solutions were divided. Using BJ3DP technology, a PN printing solution was sprayed into the tablet to prevent medication deterioration caused by light and other factors. For this experiment, an LEV- PN compound with extraordinary mechanical properties was developed. This work involved precisely controlling the volume of a single- layer inkjet by varying the size and quantity of drug- containing droplets. Lisinopril and spironolactone were dissolved in light- curing biological inks before being injected into a two- chamber pharmaceutical carrier that was 3D printed with a binder- jet printer and a piezoelectric nozzle. During production, the subse­quent treatment stopped the right drug solution from being absorbed into the carrier tablet, and each chamber held 250 L of drug solution (Goole et al., 2016 and Chen et al., 2022).
6.4 PROCESS PARAMETERS AND OPTIMIZATION FOR
PHARMACEUTICAL APPLICATION
6.4.1 rheOlOgical PrOPerties anD FlOw BehaViOr OF Pharmaceutical
BinDers
In BJ, viscosity is a deciding factor. It is determined by surface tension: Weber number (We) and Reynolds numbers (Re). These two factors decide the behavior of liquid binding with respect to drop formation during ink jetting. They are dened as follows:
Re = ÞdV/ ƞ
We = ÞdV2/ γ
where Þ = density of liquid, V = ow speed, d = droplet diameter, ƞ = dynamic vis­cosity, γ = surface tension.
Normally binding jetting technology uses a drop- on demand inkjet depos­ition which acts by pushing liquid from a small nozzle with pressure as depicted in Figure 6.2. Jettability of a uid can be determined by Ohnesorge number. It is a dimensionless variable. Liquid binders with Oh numbers 0.1 to 1 are used.
6.4.2 BinDer PenetratiOn anD BOnDing strength OPtimizatiOn
FOr Drug DeliVery systems
Two types of print heads are as follows:
( Drop- on demand (DoD) printheads; (2) continuous jet print heads.
https://t.me/med1917
Binder Jetting
107
FIGURE 6.2 (A) Continuous jet print head, (B) Drop on demand print head. (C) Various modes
of a droplet formation. (Soltman et al., 2008, Copyright 2008 American Chemical Society)
The DoD works by creating single drops on demand, DoD print heads are as follows: piezoelectric and thermal ink jet heads. Ink droplets are squeezed out in a specic shape using piezoelectric print heads. Liquid binder droplets are continuously produced in continuous- jet print heads (Goole et al., 2016). Print head speed, binder diffusion rate, drop- to- drop distance, and line spacing are some of the variables that can affect pattern techniques and droplet deposition. Binder droplets migrate because of gravity or capillary pressure until equilibrium is reached. The factors that inuence penetration depth (D) and binder spread (W) are powder morphology, particle surface chemistry, powder bed compactions, binder velocity and its chemistry, powder tem­perature, and binder bed compactions. Smaller line spacing increases the likelihood of oversaturation and bleeding while also slowing down printing. Too much space between the lines causes marginal stitching between them (Goole et al., 2016). The shape, mean size, and dispersion of the powder can all affect its mobility. In an effort to minimize powder segregation in ink jet 3D printing, hybrid binder is developed. In recent times, scientists have been working with using a suspension of nanoparticles to bind the metal powder bed particles. Submicron particles in the polymeric binder help to increase the density of the green parts (Awad et al., 2019). The interaction between binder and powder bed during the process regulates the geometry, precision, strength of the green component, and nal surface texture as described in Figure 6.3. The liquid binder wets the powder bed surface as soon as it enters into contact with the top surface of the powdered material. Due to the kinetic energy of the binder droplets, enabling the binder spread over the powder bed, a network of liquid bridges connecting the nearby particles forms in microseconds (Vithani et al., 2018).
6.4.3 Print Parameters’ OPtimizatiOn
For printing purposes, it describes the height of the powder bed along the Z axis. The range is from 15 to 300 m. The powder bed’s density decreases as layer thickness increases. Print speed is primarily determined by the combination of the recoat,
https://t.me/med1917
108
FIGURE 6.3 SLA technique showing a vat of liquid resin photopolymer from which the
3Dmodel is built layer by layer and cured by UV light. (Mostafaei et al., 2021)
Handbook of 3D Printing in Pharmaceutics
oscillator, and roller traverse speeds. It is based on the system’s ability to support print head drops when necessary as shown in Figure 6.4. Inadequate binder saturation can lead to a powder bed that does not maintain homogeneity as well as printed goods that are not precise in terms of dimensions. Following is an estimation of binder sat­uration: S = 1000XV/ (1- (PR/ 100))XY Z.
Here, V- binder volume per drop, and PR packing pace. The layer thickness is Z, and the binder droplet spacing is X and Y.
Drying time is inuenced by a number of variables, including the choice of binder saturation level, binder composition, and chemistry, layer thickness, powder wettability with binder, and packing density as mentioned in Figure 6.5. Thermal con­ductivity, surface area, permeability, and packing density are further considerations, controlled by heater power. Therefore, the green components’ distortion, shrinkage, dimensional accuracy, and surface polish are affected by the liquid binder’s drying period (Vithani et al., 2018). The layer stacking orientation refers to the position of the object being printed with respect to the Z axis, which is the stacking direction of the roller. The build orientation describes how the printed parts are positioned in rela­tion to the x, y, and z axes. The manufacturing parts’ quality is signicantly degraded (van den Heuvel et al., 2021).
6.5 QUALITY CONTROL AND CHARACTERIZATION OF BINDER
JETTED PHARMACEUTICAL PRODUCTS
6.5.1 mechanical testing anD material characterizatiOn
The following are some of the crucial aspects of powder that BJ 3DP frequently considers: the powder spreading process is important because it inuences the part’s
https://t.me/med1917
Binder Jetting
109
FIGURE 6.4 (A) CAD model, STL le, and binder jetted parts (Ingaglio et al., 2019),
(B) Diagram illustrating various components of binder jet printers using two different powder feeding methods: (left) powders are supplied via a hopper that oscillates, distributing the powder on the powder bed and achieving powder compaction with a roller (the Innovent or M- Flex ExOne printer, for example); (right) powder supply as a feeder that uses a roller to swipe powder on the powder bed on the upper layer of the built area (the X1- Lab printer, for example). (Mostafaei et al., 2021)
homogeneity and density. Other factors to consider are the powder’s owability, packing density, and particle characteristics such as morphology, particle size, and size distribution as shown in Figure 6.6. Studies using powder beds have been done to investigate the results of powder distribution. Through experimental process opti­mization work in BJ with regard to the powder spreading parameters, such as layer thickness and spreading speed, the characteristics of the green component have been improved (Goole et al., 2016).
6.5.2 Drug– exciPient cOmPatiBility anD staBility stuDies
BJ is suitable with almost any powdered material because many powdered metals and ceramics are presently sintered to their complete densities. New binders must, however, satisfy a number of requirements in order to work with the process and increase green strength. Some of these requirements for binders include viscosity, surface tension, stability, reactivity with the components inside the inkjet print head, and compatibility with the printed material (Goole et al., 2016).
The consistency and stability of the droplet formation process will be impacted by the viscosity, density, and surface tension of the binder, ultimately inuencing the
https://t.me/med1917
110
Handbook of 3D Printing in Pharmaceutics
FIGURE 6.5 Schematic representation of BJ3DP followed by post processing. (Do et al., 2017)
printing result. Finally, for components with pre- designed channels, a 10% binder level was adequate to guarantee adequate handling stability, sintering, and particle packing (Goole et al., 2016).
6.5.3 DissOlutiOn anD Drug- release testing
Modern inkjet printing has made it possible for medications that are not very water soluble to dissolve more quickly. It is carried out using the USP (type I or type II) dissolving test instrument. Samples were collected at various periods, and the HPLC method was used to examine them (Gottschalk et al., 2023).
6.5.4 In Vitro anD In Vivo PerFOrmance assessment
The relationship between an in vivo absorption prole and an in vitro drug dissolution curve is dened in large part by IVIVCs. The curves depend on the active pharma­ceutical ingredient’s (API) qualities and nature, which affect its solubility and rate of dissolution, the formulation’s release prole, and the pH of the apparatus, dissolving medium, and procedure factors. The several elements inuencing the drug’s in vivo release, include pH, surfactant, bile, ionic strength, and mobility (Goole et al., 2016).
6.6 CASE STUDIES AND EXAMPLES
6.6.1 case stuDy 1: BJ OF custOmizeD Oral DOsage FOrms
A thorough and systematic development process for drop- on powder 3D printing also referred to as binder jetting of tablets containing substantial quantities of an
https://t.me/med1917
Binder Jetting
111
FIGURE 6.6 (A) Micrographs of powder materials prepared using (Li et al., 2010) (A) gas
atomization, and (B) water atomization (Tan et al., 2017), and (C) Variations of size distribution in powder materials.
amorphized, poorly soluble drug is documented in this article. Using copovidone as the matrix polymer and ketoconazole as the model drug, the molecule was amorphized by hot melt extrusion with drug loadings of 20% and 40% (Goole et al., 2016).
6.6.2 case stuDy 2: Patient- sPeciFic imPlants anD meDical DeVices
Phosphoric acid and polyvinyl alcohol (PVA) implants were created using the BJ3DP method. According to studies, the mechanical characteristics of the implants were barely affected by various HA and TCP composition ratios. A bone tissue implant containing HA powder was printed in order to enhance the bonding between the powdered HA and the HA within the implant. In terms of good printability, geo­metric precision, and compressive strength, the nal testing results indicated that a combination of high molecular mass polyvinyl alcohol powder and HA performed
https://t.me/med1917
112
Handbook of 3D Printing in Pharmaceutics
better than commercial calcium sulfate bone implants. For bone tissue engineering applications, phosphoric acid implants with a HA/ - TCP weight ratio of 60:40 would be the ideal choice due to their mechanical and biocompatible characteristics. Along with the weight ratio of HA to TCP, the implants’ compressive strength increased. Using 3DP technology, they produced porous TCP phosphate and silica implants. Two substances that promote early bone development and mineralization upon implantation are iron and silicon. New blood vessels began to form after 12 weeks, which aided in the healing of the wound (Chen et al., 2022).
6.6.3 case stuDy 3: BJ FOr cOntrOlleD- release Drug DeliVery systems
In 1996, the rst controlled- release tablet developed utilizing binder- jet 3D printing with methylene blue and alizarin yellow as model medications and a pie- shaped controlled- release tablets were created by using acetaminophen as the model medi­cation. A signicant amount of a drug- release blocking substance was also present in high concentration in the annular region encircling the tablet. The drug- release area of the inner hole rises synchronously while the drug- release area of the outside cylindrical surface gradually declines. The height of the pill and the rate of medica­tion release remained virtually unchanged throughout time. Another oral controlled­release medication delivery method was also created employing binder- jet 3D printing and diclofenac sodium that was dissolved in the binder. Lactose, HPMC, and PVP were combined to create the powder that made up the core layer, while the top and bottom layers were made to restrict release in an axial direction. Four lateral sections were created by dividing the model from inside to outside. Reducing the amount of binder spray at each location from inside to outside altered the drug gradient. The radial two- dimensional controlled release from the three- dimensional natural release was achieved by the drug- delivery method through the use of vertical up- and- down release inhibition. In order to compensate for the smaller drug release zone, the con­trolled release function might be achieved by raising the radial drug concentration (Goole et al., 2016). Examples of porous implants for bone tissue regeneration on BJ3DP include various combinations of powders, binders, and layer thicknesses. One such example uses α- tricalcium phosphate, hydroxyapatite (HA), and polyvinyl alcohol with a 10% phosphoric acid solution as a binder, and a water- based binder, with layer thicknesses of 50 µm and 100 µm. Another example utilizes a mixture of calcium sulfate hemihydrate, HA, and tricalcium phosphate with a 2- pyrrolidinone solution and phosphate buffer with Tween 80, both having a layer thickness of 89 µm. A third example features α- tricalcium phosphate, HA microsphere binder, and a MgO/ ZnO- TCP mixture with a 2% dihydrogen sodium phosphate solution, with a layer thickness of 90 µm.
6.7 REGULATORY CONSIDERATIONS AND CHALLENGES
Lack of a regulatory framework is another major barrier to producing pharmaceuticals using this technology. Despite the fact that the FDA has only approved one 3D­printed pharmaceutical product (Spritam), the agency did issue guidelines in 2017 outlining the legal prerequisites for producing medical devices. Regulating the use of
https://t.me/med1917
Binder Jetting
113
3D printing to create dosage forms has, regrettably, not yet been done by any regu­latory body (Chen et al., 2022). Furthermore, it is unclear at this time whether the regulatory approval will apply to the entire product or just to a set of specications covering every component of the product as well as all phases of development and production (Goole et al., 2016).
Binder jetting needs to be reliable and consistent throughout the entire process cycle in order to be used as a manufacturing method for large physical size and quan­tity end use parts. For all AM processes, achieving consistency in a process where each part is unique presents a signicant challenge because geometry causes vari­ation on a wide range of processes and part parameters. Parts that need to be sintered to full density as a single alloy can be handled by binder jetting with ease, but obtaining the desired nal geometry requires multiple exploratory sintering attempts for parts that vary greatly in print. The main issues are erosion and slumping, even in cases of inltration where shrinkage is only 1 to 2 percent (Chen et al., 2022). However, depending on the nal density that is established by the green density, holding temperature, and time, a binder jetted and sintered part may shrink by up to 25% after sintering. Swelling usually occurs more in the z- direction but more simi­larly in the x- and y- directions due to reduced packing density between layers and gravity. Because of differences in the density of the powder bed within or between layers, the green portion develops anisotropic properties that further distort the part during the sintering process. A change in packing density, powder displacement, or the z- dimension of the 3D- printed part may also result from the weight of the accumulating powder layers compressing the lower layers as the z- height increases. Therefore, further research into inltration and complex geometry sintering is needed, if desired. While some research has been conducted on the creation of com­plex overhang structures, further investigation is needed to look at different feature types and the effects of powder properties, print process parameters, and furnace conditions on geometry distortion.
Differential shrinkage rates within the part as a result of thermal gradients are a signicant cause of distortion during sintering. The nal part will have incorrect geometry and undesirable properties if there is any unpredictable shrinkage rate or distortion. It takes gradual temperature ramping to get past this problem. Furthermore, the part may form in a semi- solid or even liquid phase at the sintering temperature due to its composition and hot spots in the sintering sample. This makes shape reten­tion and prediction for binder- jet 3D printed parts even more difcult. Applying non­reactive powder (such as alumina powder) to the affected areas is a workable way to reduce the heat gradient. Additionally, the use of reactive binder is recommended, which improves part strength and shape retention by forming interparticle bridges between nano- crystalline structures during the initial stage of sintering. To simulate shrinkage and sintering, part distortion can be predicted theoretically through mod­eling. Additionally, adding nanoparticles has been found to reduce slumping and shrinkage.
A few studies looked at how printing parameters and powder affected the develop­ment of layering defects in binder- jetted parts. Because of the high- velocity binder and the potential for improper binder spreading, ultra- ne powder may be ejected from the powder bed’s upper surface due to binder effects like impact and powder– binder
Соседние файлы в папке Библиотека им академика М.И. Перельмана